Disease Course Differences in Acute Pancreatitis Based on Etiology Using the Pancreatitis Activity Scoring System
To the Editor:
T he disease course of acute pancreatitis (AP) is not well defined with most studies focusing on mortality.
1,2 Improved intensive care unit care and aggressive management have improved mortality rates, 3 potentially increasing the risk for recurrent and chronic pancreatitis. 4 Detailed information of the natural disease course is important to treat patients before these irreversible damage occurs. The recent development of the Pancreatitis Activity Scoring System (PASS) can assess disease activity at any given time during an episode of AP, 5 and its individual components give more information beyond mortality.
The objective of this study was to evaluate the variations of AP disease course based on etiology using the newly described PASS.
MATERIALS AND METHODS
A retrospective review of patients from January 2014 to December 2014 at Cedars-Sinai Medical Center (approved by the Institutional Review Board, number 38294) was performed using discharge diagnosis International Classification of Diseases, Ninth Revision, code 577.0. Manual chart review confirmed that patients met the criteria for AP. 6 Transfers from outside hospitals were excluded.
Pancreatitis Activity Scoring System and its individual components were modeled using a Generalized Linear Mixed Model.
RESULTS
One hundred seventy five patients qualified for this study: 30 (17%), alcohol; 64 (37%), gallstones; and 81 (46%), idiopathic. The median baseline PASS for alcohol, gallstones, and idiopathic was 237.5, 160, and 215, respectively; the median discharge PASS for the three groups was 90, 65.6, and 80 (Table 1) .
Organ failure, change in morphine usage, and ability to tolerate solid diet were similar among the 3 groups. The alcoholic group had a higher average abdominal pain score compared with the gallstone and idiopathic groups (P < 0.0067, P < 0.0003) for patients with length of stay of 5 days.
For patients with length of stay of 3 and 5 days, the alcoholic group had a larger baseline systemic inflammatory response syndrome (SIRS) compared with the gallstone group (P < 0.0104, P < 0.0134, respectively) ( Fig. 1) . The alcoholic group also had a larger baseline SIRS compared with the idiopathic group for patients with length of stay of 5 days (P < 0.0086). The SIRS at day 5 for patients with length of stay of 5 days was higher in the alcoholic group compared with the gallstone group (P < 0.0071) and the idiopathic group (P < 0.0029).
DISCUSSION
This study describes in detail, the disease course of AP stratified by etiology using the recently validated PASS. We found that patients with alcoholic pancreatitis had a higher baseline and discharge PASS; alcoholic pancreatitis had a higher level of baseline and discharge SIRS and higher abdominal pain score for patients with higher length of stays. The SIRS trend was also interesting; whereas both gallstone and idiopathic groups showed improvement throughout, the alcohol group showed minimal improvement and worsened after day 4. Alcoholic pancreatitis is thought to have a more severe form of AP and increased risk for recurrent AP and chronic pancreatitis, 7 which can potentially be explained by the diffuse negative effects of alcohol throughout the body. 8 The small sample size and the retrospective nature of the study are limitations of this study. Future studies should be performed with larger cohorts in a prospective manner.
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Los Angeles, CA daniel.lew@cshs.org C hronic pancreatitis is often considered a contraindication to heart transplantation (HTx). It occurs 15 to 30 times more frequently after HTx. 1 Pancreatitis is difficult to diagnose and cryptosymptomatic because of the suppressed inflammatory response from immunosuppression and hepatic dysfunction from congestive hepatopathy. [1] [2] [3] We describe the complex medical considerations surrounding HTx in a complex congenital cardiac patient with chronic pancreatitis.
A 21-year-old woman with a history of tricuspid atresia and pulmonary atresia status post Glenn and fenestrated Fontan complicated by severe protein-losing enteropathy was diagnosed with pancreatitis while awaiting HTx. Abdominal ultrasound showed no radiographic evidence of pancreatitis, although she had episodes of severe abdominal pain and elevated lipase at 1031 U/L. She was initially delisted for HTx; however, given her clinical decline and stable chronic pancreatitis, she was reevaluated for HTx. Significant concerns included perioperative risk and mortality from acute exacerbation of her chronic pancreatitis triggered by poor pancreatic perfusion from end-stage heart disease, prolonged cardiopulmonary bypass time, and the adverse effects of immunosuppressive drugs after HTx. 1 Pancreatitis is a reported adverse effect of tacrolimus, azathioprine, and mycophenolate mofetil. 1, 2 Pretransplant evaluation included endoscopic ultrasound, which revealed a normal biliary tree and a diffuse, hypoechoic and heterogeneous pancreas without stranding suggestive of mild to moderate pancreatitis. The cause of her pancreatitis was unclear, and the differential broad in the context of a failing Fontan physiology. She initially developed pancreatitis after cholecystectomy for symptomatic gallstones. Acute pancreatitis after cholecystectomy occurs in less than 0.4% of cases. 4 Imaging showed no retained gallstones or hemobilia, and no reversible cause of pancreatitis was discovered. 4 A liver biopsy showed chronic congestive hepatopathy with focal bridging fibrosis. Pancreatic surgery service was consulted to evaluate her perioperative mortality risk and eventually possible alternatives including pancreatectomy. There was no indication for pancreatectomy given that her computed tomography scan of the abdomen/pelvis scan showed no evidence of chronic pancreatitis, and besides her persistent elevation of serum lipase, she was oligosymptomatic. Highly complex HTx was performed. Cardiopulmonary bypass time was 341 minutes because of surgical complexity. Operative course was complicated by supraventricular tachycardia requiring cardioversion and profound hypothermia. After coming off pump, she developed significant bleeding and depressed right ventricular function requiring blood products and inotropes. She also underwent delayed chest closure because of her dextrocardia and a heart-chest size discrepancy. After HTx, she received mycophenolate mofetil, methylprednisolone (Solu-Medrol), and tacrolimus. At the time of transplantation, her lipase was 1220 U/L, which improved after HTx to 400 to 800 U/L. She was discharged after 60 days and remained clinically well with normal graft function and no rejection or other major complications.
There are no previous reports of HTx in patients with chronic pancreatitis. In this case, we demonstrate that carefully evaluated patients can successfully undergo HTx even in the complex setting of failing congenital heart disease. Patients with chronic pancreatitis must undergo rigorous evaluations to assess for reversible causes and demonstrate stable disease with an estimated low risk of developing acute pancreatitis. Close follow-up after HTx is critical as the presentation can often be obscured by immunosuppression.
Jennifer Phung Woo, MD
